Human T cells modulate myeloid-derived suppressor cells through a TNF-α-mediated mechanism

被引:8
|
作者
Bauswein, Markus [1 ]
Singh, Anurag [1 ]
Ralhan, Anjali [1 ]
Neri, Davide [1 ]
Fuchs, Katharina [1 ]
Blanz, Kelly Daryll [1 ]
Schaefer, Iris [1 ]
Hector, Andreas [1 ]
Handgretinger, Rupert [1 ]
Hartl, Dominik [1 ,2 ]
Rieber, Nikolaus [1 ,3 ,4 ]
机构
[1] Univ Tubingen, Dept Pediat 1, Tubingen, Germany
[2] Roche Innovat Ctr Basel, Immunol Inflammat & Infect Dis I3 Discovery & Tra, Roche Pharma Res & Early Dev pRED, Basel, Switzerland
[3] StKM GmbH, Klinikum Schwabing, Kinderklin Muenchen Schwabing, Dept Pediat, Munich, Germany
[4] Tech Univ Munich, Klinikum Rechts Isar, Munich, Germany
关键词
Myeloid-derived suppressor cells; MDSC; PMN-MDSC; T cells; TNF-alpha; IL-2; Crosstalk; Reciprocal; Apoptosis; HUMAN NEUTROPHILS; GENE-EXPRESSION; INTERLEUKIN-2; BIOLOGY; ACCUMULATION; NOMENCLATURE; ACTIVATION; IL-2;
D O I
10.1016/j.imlet.2018.07.010
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Myeloid-derived suppressor cells (MDSC) represent an innate immune cell subset capable of suppressing T-cell responses in cancer and chronic inflammation. While the effect of MDSC on T cells has been defined thoroughly, the reciprocal impact of T cells on MDSC homeostasis remains poorly understood. Therefore, we comprehensively analyzed the effect of different T-cell subsets on the generation and survival of human MDSC. Using an in vitro MDSC generation assay, we demonstrate that unstimulated CD4(+), but not CD8(+) T cells, induce polymorphonuclear MDSC (PMN-MDSC) from CD33(+) myeloid cells. This effect was dependent on direct cell-cell contact and required TNF-alpha signaling. Soluble TNF-alpha was dispensable for PMN-MDSC generation, suggesting that transmembrane TNF-alpha is involved in that trans-cellular process. Stimulated human CD3(+) T cells delayed the apoptosis of PMN-MDSC, which was independent of TNF-alpha signaling or direct cell-cell contact, but was recapitulated by IL-2. Taken together, our study shows that human T cells modulate MDSC generation and survival through two distinct mechanisms and thereby fine-tune the homeostasis of human MDSC in a regulated manner.
引用
收藏
页码:31 / 37
页数:7
相关论文
共 50 条
  • [21] Myeloid-derived suppressor cells in cancer
    Bronte, Vincenzo
    JOURNAL OF IMMUNOTHERAPY, 2007, 30 (08) : 878 - 878
  • [22] Myeloid-derived suppressor cells in glioma
    Mirghorbani, Masoud
    Van Gool, Stefaan
    Rezaei, Nima
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2013, 13 (12) : 1395 - 1406
  • [23] Myeloid-Derived Suppressor Cells and Radiotherapy
    Jimenez-Cortegana, Carlos
    Galassi, Claudia
    Klapp, Vanessa
    Gabrilovich, Dmitry, I
    Galluzzi, Lorenzo
    CANCER IMMUNOLOGY RESEARCH, 2022, 10 (05) : 545 - 557
  • [24] EBV and myeloid-derived suppressor cells
    Sinha, Debottam
    Khanna, Rajiv
    BLOOD, 2021, 137 (02) : 148 - 150
  • [25] Myeloid-derived suppressor cells: A new escape mechanism of melanoma
    Tsianakas, A.
    Ehrchen, J. M.
    Seeliger, S.
    Rattenholl, A.
    Steinhoff, M.
    Luger, T. A.
    Roth, J.
    Varga, G.
    Sunderkoetter, C.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2009, 7 : 165 - 165
  • [26] Myeloid-derived suppressor cells in gliomas
    Gieryng, Anna
    Kaminska, Bozena
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2016, 20 (05): : 345 - 351
  • [27] Myeloid-Derived Suppressor Cells in Sepsis
    Lai, Dengming
    Qin, Chaojin
    Shu, Qiang
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [28] Defining myeloid-derived suppressor cells
    Akkari, Leila
    Amit, Ido
    Bronte, Vincenzo
    Fridlender, Zvi G.
    Gabrilovich, Dmitry I.
    Ginhoux, Florent
    Hedrick, Catherine C.
    Ostrand-Rosenberg, Suzanne
    NATURE REVIEWS IMMUNOLOGY, 2024, 24 (12) : 850 - 857
  • [29] Myeloid-derived Suppressor Cells in Sepsis
    van der Poll, Tom
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 196 (03) : 256 - 258
  • [30] A New Mechanism for Blocking Myeloid-Derived Suppressor Cells by CpG
    Lechner, Melissa G.
    Epstein, Alan L.
    CLINICAL CANCER RESEARCH, 2011, 17 (07) : 1645 - 1648